Global Health Limited Schedules Board Meeting on May 14, 2026 to Approve FY26 Audited Results and Consider Final Dividend

Global Health Limited has notified the stock exchanges of a forthcoming board meeting scheduled for Thursday, May 14, 2026. The intimation was filed on May 06, 2026, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will address key financial and corporate governance matters pertaining to Financial Year 2025-26.

Agenda for the Board Meeting

The board meeting has been convened to deliberate on the following key items:

Agenda Item:	Details
Financial Results:	Consider and approve audited financial results for the quarter and year ended March 31, 2026
Dividend Recommendation:	Consider and recommend final dividend, if any, on equity shares, subject to shareholder approval at the Annual General Meeting for FY 2025-26

The dual agenda underscores the significance of the meeting, covering both the company's full-year financial performance disclosure and a potential return of value to shareholders.

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code for Prevention of Insider Trading, Global Health Limited has confirmed that the trading window for its securities is already closed effective April 01, 2026. The trading window will reopen 48 hours after the declaration of the aforementioned financial results.

The intimation was signed by Rahul Ranjan, Company Secretary & Compliance Officer (M. No. A17035), on behalf of Global Health Limited, and has been submitted to both BSE Limited and the National Stock Exchange of India Limited for their records.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.52%	+7.46%	+16.19%	-4.09%	-0.85%	+189.09%

Global Health Limited has announced a major corporate development with its board signing a deal to transfer a specialized cancer hospital facility in Indore. The transaction represents a significant strategic move for the healthcare company as it continues to optimize its operational portfolio.

Transaction Details

The deal involves the transfer of a 79-bed cancer hospital facility located in Indore, highlighting the substantial scale of the healthcare infrastructure involved in this transaction.

Parameter:	Details
Transaction Value:	₹30 crores
Facility Type:	Cancer Hospital
Bed Capacity:	79 beds
Location:	Indore
Target Completion:	September 30, 2026

Strategic Implications

The board's approval of this transfer deal demonstrates Global Health Limited's active approach to portfolio management within the healthcare sector. The specialized nature of the facility as a cancer hospital underscores the significance of this transaction in the oncology care segment.

Timeline and Completion

The company has set a clear timeline for the deal completion, with September 30, 2026, established as the target date. This extended timeline suggests a structured transition process that will likely involve comprehensive handover procedures and regulatory compliance requirements typical of healthcare facility transfers.

The transaction value of ₹30 crores reflects the substantial investment involved in transferring a specialized healthcare facility of this magnitude, particularly one focused on cancer treatment services.